What is IPF Phase III CAPACITY 2 (pirfenidone)?

Category: Others

true

Generic name: Pirfenidone

The CAPACITY 2 trial was a Phase III, placebo controlled trial of the safety and efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis. NCT00287716

What people switch to and from

Patients started taking IPF Phase III CAPACITY 2 (pirfenidone) after stopping:

Treatment Patients
Formoterol-mometasone (Dulera) 1
Nintedanib (Ofev) 1

Patients stopped taking IPF Phase III CAPACITY 2 (pirfenidone) and switched to:

Treatment Patients
Nintedanib (Ofev) 1
Last updated:
There are no evaluations for IPF Phase III CAPACITY 2 (pirfenidone).